CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.260

-3.8%

3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SemiBull who wrote (362)	2/25/2001 10:39:25 PM
From: Jim Oravetz	Read Replies (1) of 668

Engineering Tissue Growth Int'l Conference & Expo. March 26-29. Marriott City Center Pittsburgh, PA Thur. March 29th. Soft Tissue Engineering Applied Biology Section, Morning 9-9:30am "Regenerative Medicine and Tissue Engineering" Dr. Doros Platika, Pres. and CEO, Curis Regenerative medicine and tissue engineering products are grounded in a detailed understanding of the biological processes responsible for cell and tissue growth. The convergence of genomics, developmental biology, bioinformatics, and stem cell technology has generated these innovative products and product candidates. Tissue engineering product development at Curis includes the use of stem cells and appropriate biomatrices, along with therapeutics that activate the body's inherent ability to repair damage caused by disease, trauma, or aging.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next